(Q42993714)

12 November 2017

title

Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees (English)

1 reference

12 November 2017

1 reference

Bassett SE

1

1 reference

12 November 2017

Di Bisceglie AM

2

1 reference

12 November 2017

Bacon BR

3

1 reference

12 November 2017

Sharp RM

4

1 reference

12 November 2017

Govindarajan S

5

1 reference

12 November 2017

Hubbard GB

6

1 reference

12 November 2017

Brasky KM

7

1 reference

12 November 2017

Lanford RE

8

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

12 November 2017

1 reference

12 November 2017

volume

29

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

1884-1892

1 reference

National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Epidemiology of Hepatitis C in the West

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Iron and chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Measurements of iron status in patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Iron overload in patients with chronic hepatitis C: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Response to interferon alpha therapy is influenced by the iron content of the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Failure to respond to interferon-alpha 2a therapy is associated with increased hepatic iron levels in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic implications

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Hepatic lipid peroxidation in vivo in rats with chronic iron overload

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290623

7 January 2021

Identifiers

DOI

10.1002/HEP.510290623

1 reference

12 November 2017

1 reference